Trop2 also exhibits tumor suppressive functions in cervical cancer cells, where it similarly inhibits the activation of IGF-1R and anaplastic lymphoma kinase (ALK), possibly through binding to their ligands IGF-1 and midkine (MDK) [77]. This evidence concerns the gene TACSTD2 and cervical cancer.